Price to Sales ratio Analysis of Marksans Pharma - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsLatest FY PS
Period Ending - Mar-25
Very Poor PS
4.63
Period Ending - Mar-24
Very Poor PS
3.16
Growth
46.46 %
Trailing Twelve Months PS
Period Ending - Mar-25
Poor PS
2.91
PS Analysis of Marksans Pharma
| PS Ratio of MARKSANS rose handsomely by 46.46 % this year. |
| PS Ratio of MARKSANS trending up for at least three Years. |
| PS Ratio with value of 1.25 was lowest in Year Mar-22 in last Five Years. |
| Latest PS Ratio with value of 4.63 is Greater than Average PS of 2.42 in last five years. |
Other PS Related Info of MARKSANS that may interest you.
Marksans Pharma Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| MARKSANS | 180.18 | 178.92 | 0.704 % | Health Services |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..
PS Related Ratios
| PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
| Very Low Value Stock | Screener |
FY - Historical Price to Sales of Marksans Pharma
| Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 |
|---|---|---|---|---|---|---|---|
| PS | 4.63 | 3.16 | 1.58 | 1.25 | 1.49 | 0.502 | 1.02 |
| Change | 46.46 % | 100.26 % | 26.41 % | -15.91 % | 196.17 % | -50.88 % | -28.06 % |
| Price | 222.47 | 151.90 | 70.40 | 45.50 | 49.95 | 13.90 | 24.95 |
| Price Change | 46.46 % | 115.77 % | 54.73 % | -8.91 % | 259.35 % | -44.29 % | -21.17 % |
FY Chart of Price to Sales of Marksans Pharma
Value Investing eBook
Free PDF eBook on Value Investing
Value Investing eBook
Free PDF eBook on Value Investing